Long-Acting Injectable Risperidone and Hospital Readmission: A Mirror-Image Study Using a National Claim-Based Database in Taiwan
J Clin Psychiatry 2009;70(1):141 [letter]
© Copyright 2015 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Letter to the Editor
Sir: Poor compliance with antipsychotic medication, which
would potentially lead to disease relapse, has been challenging
for psychiatrists when treating schizophrenia. Long-acting
injection of antipsychotics is an appropriate alternative, since
better compliance improves treatment outcomes. Mirror-image
studies, in which each patient acts as his/her own control,
of long-acting injection of conventional antipsychotics have
shown significant decreases in numbers of hospitalizations and
days of hospitalization.